Complete Filing Data
Tyra Biosciences, Inc. reported Stockholders Equity of $259.18 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Tyra Biosciences, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$119.9M | -$86.5M | -$69.1M | -$55.3M | -$26.3M | -$9.3M |
| Research And Development Expense | $102.9M | $80.1M | $62.5M | $43.0M | $20.6M | $7.2M |
| Operating Income Loss | -$132.8M | -$104.2M | -$79.9M | -$58.9M | -$26.3M | -$9.3M |
| Operating Expenses | $132.8M | $104.2M | $79.9M | $58.9M | $26.3M | $9.3M |
| Nonoperating Income Expense | $12.8M | $17.7M | $10.8M | $3.6M | -$6.0K | -$39.0K |
| General And Administrative Expense | $29.8M | $24.1M | $17.4M | $15.9M | $5.7M | $2.1M |
| Other Nonoperating Expense | $39.0K | $50.0K | $19.0K | $23.0K | ||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -$377.0K | $389.0K | $381.0K | $0.00 | ||
| Investment Income Interest Expense | $10.9M | $3.7M | $13.0K | -$1.0K | ||
| Comprehensive Income Net Of Tax | -$120.3M | -$86.1M | -$68.8M | -$55.3M | ||
| Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party | $765.0K | $435.0K | $0.00 | |||
| Selling General And Administrative Expense |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$29.9M | -$28.1M | -$28.1M | -$24.0M | -$18.7M | -$18.2M | -$21.2M | -$13.3M | -$11.9M | -$12.5M | -$15.1M | -$14.8M | -$6.6M | -$5.5M | -$4.2M | -$3.7M | -$2.3M | -$1.8M | -$1.5M |
| Research And Development Expense | $25.5M | $24.3M | $25.0M | $22.7M | $18.0M | $17.2M | $19.3M | $12.2M | $10.4M | $10.9M | $12.0M | $9.6M | $5.5M | $4.4M | $3.5M | $1.9M | |||
| Operating Income Loss | -$32.9M | -$31.5M | -$31.9M | -$28.6M | -$23.5M | -$22.3M | -$24.0M | -$16.0M | -$14.3M | -$13.6M | -$15.4M | -$14.8M | -$6.6M | -$5.5M | -$4.2M | -$2.3M | |||
| Operating Expenses | $32.9M | $31.5M | $31.9M | $28.6M | $23.5M | $22.3M | $24.0M | $16.0M | $14.3M | $13.6M | $15.4M | $14.8M | $6.6M | $5.5M | $4.2M | $2.3M | |||
| Nonoperating Income Expense | $3.1M | $3.4M | $3.7M | $4.6M | $4.8M | $4.1M | $2.8M | $2.7M | $2.5M | $1.1M | $333.0K | $8.0K | -$5.0K | -$4.0K | $2.0K | -$7.0K | |||
| General And Administrative Expense | $7.5M | $7.1M | $6.9M | $5.9M | $5.5M | $5.1M | $4.7M | $3.9M | $3.9M | $2.7M | $3.4M | $5.2M | $1.2M | $1.1M | $689.0K | $470.0K | |||
| Other Nonoperating Expense | $21.0K | $1.0K | $5.0K | $13.0K | $10.0K | $7.0K | $8.0K | $0.00 | $7.0K | ||||||||||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $6.0K | -$252.0K | -$82.0K | $1.9M | -$178.0K | -$387.0K | $0.00 | $0.00 | $0.00 | ||||||||||
| Investment Income Interest Expense | $2.8M | $2.8M | $2.5M | $1.1M | $346.0K | $18.0K | $2.0K | $4.0K | $2.0K | ||||||||||
| Comprehensive Income Net Of Tax | -$29.9M | -$28.4M | -$28.2M | -$22.1M | -$18.9M | -$18.6M | -$21.2M | -$13.3M | -$11.9M | ||||||||||
| Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party | $0.00 | $173.0K | $186.0K | $210.0K | $142.0K | $118.0K | $0.00 | $0.00 | |||||||||||
| Selling General And Administrative Expense | $0.00 | $0.00 | $173.0K | $186.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $259.2M | $343.2M | $204.3M | $257.8M | $301.7M | -$13.6M | -$4.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $78.4M | $93.0M | $59.0M | $252.2M | $302.4M | $15.5M | $108.0K |
| Vesting Of Shares Of Common Stock Subject To Repurchase | 43.0K | 124.0K | 197.0K | 199.0K | |||
| Issuance Of Common Stock Under Benefit Plans | $8.3M | $2.6M | $1.5M | $632.0K | $89.0K | ||
| Cash And Cash Equivalents At Carrying Value | $77.4M | $92.0M | $58.0M | $251.2M | $302.2M | $15.2M | |
| Restricted Cash Noncurrent | $1.0M | $1.0M | $1.0M | $1.0M | $243.0K | $243.0K | |
| Retained Earnings Accumulated Deficit | -$371.3M | -$251.3M | -$164.8M | -$95.7M | -$40.4M | -$14.1M | |
| Property Plant And Equipment Net | $1.3M | $1.7M | $1.6M | $1.1M | $1.0M | $297.0K | |
| Prepaid Expense And Other Assets Current | $9.4M | $6.0M | $8.2M | $6.1M | $1.9M | $57.0K | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Other Liabilities Noncurrent | $0.00 | $3.0K | $46.0K | $169.0K | $367.0K | $140.0K | |
| Other Assets Noncurrent | $9.3M | $7.4M | $5.0M | $4.4M | $312.0K | $21.0K | |
| Other Accrued Liabilities Current | $16.4M | $13.6M | $10.4M | $4.4M | $2.8M | $1.1M | |
| Liabilities Current | $18.1M | $14.6M | $15.3M | $5.7M | $3.6M | $1.9M | |
| Liabilities And Stockholders Equity | $282.6M | $363.6M | $225.9M | $266.2M | $306.7M | $16.0M | |
| Liabilities | $23.4M | $20.4M | $21.6M | $8.4M | $5.0M | $2.0M | |
| Common Stock Value | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$14.6M | $34.0M | -$193.2M | -$50.2M | $287.0M | $15.4M | |
| Assets Current | $265.5M | $347.5M | $211.7M | $257.3M | $304.1M | $15.3M | |
| Assets | $282.6M | $363.6M | $225.9M | $266.2M | $306.7M | $16.0M | |
| Additional Paid In Capital Common Stock | $630.0M | $593.7M | $368.7M | $353.5M | $342.1M | $439.0K | |
| Accounts Payable Current | $1.2M | $590.0K | $4.7M | $1.1M | $599.0K | $664.0K | |
| Operating Lease Liability Noncurrent | $5.3M | $5.8M | $6.2M | $2.5M | $981.0K | $0.00 | |
| Operating Lease Liability Current | $472.0K | $412.0K | $280.0K | $140.0K | $202.0K | $142.0K | |
| Restricted Cash And Cash Equivalents | $1.0M | $1.0M | $1.0M | $243.0K | $243.0K | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $4.4M | $1.6M | $1.2M | $101.0K | ||
| Gain Loss On Sale Of Property Plant Equipment | -$4.0K | -$3.0K | -$3.0K | -$2.0K | |||
| Marketable Securities | $178.6M | $249.5M | $145.5M | $0.00 | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $393.0K | $770.0K | $381.0K | $0.00 | |||
| Accretion On Marketable Securities Net | -$2.1M | -$5.9M | -$1.2M | $0.00 | |||
| Finance Lease Principal Payments | $0.00 | $9.0K | $17.0K | ||||
| Accounts Payable Related Parties Current | $0.00 | $47.0K | $0.00 | ||||
| Accrued And Other Related Parties | $0.00 | $59.0K | $0.00 | ||||
| Accounts Payable Accrued Expenses And Other Liabilities Related Party Transactions | $0.00 | $12.0K | $47.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $280.5M | $302.1M | $323.5M | $362.3M | $376.0M | $389.9M | $222.2M | $238.6M | $248.8M | $267.8M | $278.9M | $291.2M | $309.7M | -$22.7M | -$17.5M | -$10.1M | -$7.8M | -$6.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $63.0M | $99.5M | $101.7M | $104.9M | $100.5M | $255.4M | $216.7M | $233.4M | $242.7M | $264.2M | $276.1M | $293.5M | $313.1M | $135.4M | $140.9M | $18.1M | ||
| Vesting Of Shares Of Common Stock Subject To Repurchase | 3.0K | 9.0K | 9.0K | 17.0K | 30.0K | 31.0K | 32.0K | 37.0K | 42.0K | 63.0K | 39.0K | 28.0K | 65.0K | |||||
| Issuance Of Common Stock Under Benefit Plans | $647.0K | $583.0K | $2.2M | $743.0K | $624.0K | $484.0K | $343.0K | $494.0K | $376.0K | $356.0K | $34.0K | $238.0K | $1.0K | $1.0K | $86.0K | |||
| Cash And Cash Equivalents At Carrying Value | $62.0M | $98.5M | $100.7M | $103.9M | $99.5M | $254.4M | $215.7M | $232.4M | $241.7M | $263.2M | $275.1M | $292.5M | $312.8M | $135.2M | $140.6M | $18.1M | ||
| Restricted Cash Noncurrent | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $243.0K | |||||
| Retained Earnings Accumulated Deficit | -$337.4M | -$307.6M | -$279.5M | -$225.7M | -$201.7M | -$183.0M | -$142.0M | -$120.8M | -$107.6M | -$82.8M | -$70.3M | -$55.2M | -$30.4M | |||||
| Property Plant And Equipment Net | $1.3M | $1.4M | $1.5M | $1.8M | $1.9M | $1.6M | $1.1M | $1.1M | $1.0M | $1.1M | $1.2M | $1.0M | $779.0K | |||||
| Prepaid Expense And Other Assets Current | $6.3M | $5.9M | $5.6M | $5.5M | $4.8M | $8.3M | $9.0M | $8.3M | $5.0M | $4.3M | $2.2M | $1.5M | $678.0K | |||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Other Liabilities Noncurrent | $0.00 | $0.00 | $0.00 | $11.0K | $20.0K | $29.0K | $77.0K | $108.0K | $139.0K | $226.0K | $261.0K | $303.0K | $434.0K | |||||
| Other Assets Noncurrent | $12.6M | $11.1M | $10.4M | $6.0M | $4.7M | $5.0M | $5.3M | $866.0K | $3.9M | $3.9M | $5.1M | $362.0K | $318.0K | |||||
| Other Accrued Liabilities Current | $13.4M | $11.1M | $11.3M | $10.8M | $8.4M | $5.5M | $7.7M | $3.8M | $2.3M | $2.6M | $3.0M | $3.4M | $2.6M | |||||
| Liabilities Current | $15.9M | $13.8M | $14.2M | $12.4M | $10.4M | $8.7M | $10.1M | $5.4M | $3.7M | $5.5M | $5.5M | $4.9M | $4.8M | |||||
| Liabilities And Stockholders Equity | $301.9M | $321.5M | $343.5M | $380.6M | $392.5M | $404.7M | $238.4M | $250.0M | $255.1M | $276.0M | $287.1M | $299.0M | $316.0M | |||||
| Liabilities | $21.3M | $19.4M | $19.9M | $18.3M | $16.4M | $14.9M | $16.2M | $11.4M | $6.3M | $8.2M | $8.3M | $7.8M | $6.2M | |||||
| Common Stock Value | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $8.8M | $196.4M | -$9.5M | -$8.9M | $125.4M | |||||||||||||
| Assets Current | $281.2M | $302.2M | $324.6M | $365.6M | $378.6M | $390.8M | $224.6M | $240.7M | $246.7M | $267.5M | $277.3M | $294.0M | $313.5M | |||||
| Assets | $301.9M | $321.5M | $343.5M | $380.6M | $392.5M | $404.7M | $238.4M | $250.0M | $255.1M | $276.0M | $287.1M | $299.0M | $316.0M | |||||
| Additional Paid In Capital Common Stock | $617.5M | $609.3M | $602.3M | $586.3M | $577.9M | $572.9M | $364.2M | $359.4M | $356.4M | $350.6M | $349.1M | $346.4M | $340.2M | |||||
| Accounts Payable Current | $2.0M | $2.2M | $2.5M | $1.2M | $1.6M | $2.9M | $2.3M | $1.4M | $1.3M | $2.7M | $2.3M | $1.4M | $2.1M | |||||
| Operating Lease Liability Noncurrent | $5.5M | $5.6M | $5.7M | $5.9M | $6.0M | $6.1M | $6.0M | $5.9M | $2.4M | $2.5M | $2.5M | $2.6M | $1.0M | |||||
| Operating Lease Liability Current | $456.0K | $441.0K | $426.0K | $398.0K | $383.0K | $370.0K | $148.0K | $144.0K | $144.0K | $127.0K | $123.0K | $119.0K | ||||||
| Restricted Cash And Cash Equivalents | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $243.0K | $243.0K | $243.0K | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $1.5M | $0.00 | |||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$2.0K | $0.00 | |||||||||||||||
| Marketable Securities | $213.0M | $197.8M | $218.2M | $256.2M | $274.3M | $128.1M | ||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $442.0K | $436.0K | $688.0K | $1.8M | -$184.0K | -$6.0K | ||||||||||||
| Accretion On Marketable Securities Net | -$866.0K | -$1.2M | $0.00 | |||||||||||||||
| Finance Lease Principal Payments | $0.00 | $4.0K | ||||||||||||||||
| Accounts Payable Related Parties Current | $64.0K | $67.0K | $69.0K | $68.0K | ||||||||||||||
| Accrued And Other Related Parties | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Accounts Payable Accrued Expenses And Other Liabilities Related Party Transactions | $0.00 | $0.00 | $0.00 | $17.0K | $20.0K | $22.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $28.0M | $22.8M | $13.5M | $10.6M | $2.9M | $439.0K |
| Payments To Acquire Property Plant And Equipment | $141.0K | $664.0K | $770.0K | $559.0K | $661.0K | $312.0K |
| Net Cash Provided By Used In Operating Activities | -$95.1M | -$69.8M | -$50.1M | -$50.3M | -$23.7M | -$7.8M |
| Net Cash Provided By Used In Investing Activities | $72.5M | -$98.4M | -$144.6M | -$559.0K | -$645.0K | -$312.0K |
| Net Cash Provided By Used In Financing Activities | $8.1M | $202.1M | $1.5M | $632.0K | $311.3M | $23.4M |
| Increase Decrease In Right Of Use Assets And Lease Liabilities Net | $83.0K | $184.0K | -$186.0K | $34.0K | $135.0K | -$14.0K |
| Increase Decrease In Prepaid Expenses Other | $5.1M | $169.0K | $2.8M | $8.2M | $2.1M | -$65.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $3.4M | -$744.0K | $9.4M | $2.4M | $1.5M | $1.0M |
| Depreciation Depletion And Amortization | $546.0K | $519.0K | $357.0K | $296.0K | $140.0K | $47.0K |
| Proceeds From Issuance Of Common Stock Under Benefit Plans | $8.1M | $2.6M | $1.5M | $632.0K | $514.0K | |
| Payments To Acquire Marketable Securities | $101.3M | $263.6M | $143.8M | $0.00 | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $173.9M | $165.9M | $0.00 | |||
| Proceeds From Issuance Of Common Stock And Pre Funded Warrants From Private Placement | $0.00 | $200.0M | $0.00 | |||
| Payments Of Issuance Costs For Common Stock And Pre Funded Warrants From Private Placement | $0.00 | $420.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $6.4M | $4.1M | $2.4M | $4.0M | $174.0K |
| Payments To Acquire Property Plant And Equipment | $14.0K | $136.0K | $41.0K | $239.0K | $60.0K |
| Net Cash Provided By Used In Operating Activities | -$25.5M | -$22.0M | -$9.8M | -$8.9M | -$4.7M |
| Net Cash Provided By Used In Investing Activities | $32.0M | $18.1M | -$41.0K | -$239.0K | -$60.0K |
| Net Cash Provided By Used In Financing Activities | $2.2M | $200.3M | $376.0K | $238.0K | $130.2M |
| Increase Decrease In Right Of Use Assets And Lease Liabilities Net | $22.0K | $105.0K | $9.0K | $4.0K | $0.00 |
| Increase Decrease In Prepaid Expenses Other | $2.7M | $43.0K | -$1.5M | -$299.0K | $91.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$365.0K | -$6.9M | -$2.0M | $1.6M | -$574.0K |
| Depreciation Depletion And Amortization | $143.0K | $122.0K | $83.0K | $64.0K | $22.0K |
| Proceeds From Issuance Of Common Stock Under Benefit Plans | $2.2M | $484.0K | $376.0K | $238.0K | $533.0K |
| Payments To Acquire Marketable Securities | $6.9M | $11.8M | $0.00 | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $38.9M | $30.0M | $0.00 | ||
| Proceeds From Issuance Of Common Stock And Pre Funded Warrants From Private Placement | $0.00 | $200.0M | $0.00 | ||
| Payments Of Issuance Costs For Common Stock And Pre Funded Warrants From Private Placement | $0.00 | $169.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.01 | -$1.51 | -$1.62 | -$1.32 | -$1.91 | -$6.05 |
| Weighted Average Number Of Shares Outstanding Basic | 59.6M | 57.2M | 42.7M | 41.9M | 13.8M | |
| Weighted Average Number Of Diluted Shares Outstanding | 59.6M | 57.2M | 42.7M | 41.9M | 13.8M | |
| Earnings Per Share Basic | $-2.01 | $-1.51 | $-1.62 | $-1.32 | $-1.91 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 53.7M | 50.7M | 43.0M | 42.4M | 41.4M | 1.8M |
| Common Stock Shares Issued | 53.7M | 50.8M | 43.1M | 42.6M | 42.5M | 3.1M |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 50.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 13.8M | 1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.50 | -$0.47 | -$0.47 | -$0.41 | -$0.32 | -$0.35 | -$0.49 | -$0.31 | -$0.28 | -$0.30 | -$0.36 | -$0.36 | -$0.72 | -$2.43 | -$2.09 | -$1.47 |
| Weighted Average Number Of Shares Outstanding Basic | 59.7M | 59.6M | 59.3M | 58.9M | 58.7M | 52.2M | 42.9M | 42.6M | 42.4M | 42.0M | 41.8M | 41.6M | 9.2M | 2.3M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 59.7M | 59.6M | 59.3M | 58.9M | 58.7M | 52.2M | 42.9M | 42.6M | 42.4M | 42.0M | 41.8M | 41.6M | 9.2M | 2.3M | ||
| Earnings Per Share Basic | $-0.50 | $-0.47 | $-0.47 | $-0.41 | $-0.32 | $-0.35 | $-0.49 | $-0.31 | $-0.28 | $-0.30 | $-0.36 | $-0.36 | $-0.72 | $-2.43 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 53.3M | 53.2M | 53.1M | 52.9M | 52.7M | 52.5M | 42.9M | 42.8M | 42.5M | 42.1M | 41.9M | 41.7M | 41.2M | |||
| Common Stock Shares Issued | 53.3M | 53.2M | 53.1M | 52.9M | 52.8M | 52.5M | 43.1M | 43.0M | 42.8M | 42.6M | 42.6M | 42.6M | 42.5M | |||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 41.6M | 9.2M | 2.0M | 1.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $28.0M | $22.8M | $13.5M | $10.6M | $2.9M | $439.0K |
| Right Of Use Asset | $5.6M | $6.1M | $6.5M | $2.5M | $1.1M | $169.0K |
| Capital Expenditures Incurred But Not Yet Paid | $68.0K | $0.00 | $125.0K | $0.00 | $209.0K | $4.0K |
| Interest And Other Income | $12.8M | $17.7M | $10.8M | |||
| Vesting Of Options Early Exercised Subject To Repurchase | $3.0K | $43.0K | $124.0K | $197.0K | ||
| Availableforsaledebtsecuritiesnetunrealizedloss |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.6M | $6.4M | $6.4M | $7.6M | $4.4M | $4.1M | $4.4M | $2.5M | $2.4M | $1.0M | $2.7M | $4.0M | $507.0K | $338.0K | $174.0K | $127.0K | $106.0K | $98.0K | $108.0K |
| Right Of Use Asset | $5.7M | $5.8M | $5.9M | $6.2M | $6.3M | $6.4M | $6.2M | $6.3M | $2.4M | $2.5M | $2.5M | $2.6M | $1.1M | ||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $9.0K | $0.00 | $17.0K | $18.0K | ||||||||||||||
| Interest And Other Income | $3.1M | $3.4M | $3.7M | $4.6M | $4.8M | $4.1M | $2.8M | $2.7M | $2.5M | ||||||||||
| Vesting Of Options Early Exercised Subject To Repurchase | $3.0K | $17.0K | $32.0K | ||||||||||||||||
| Availableforsaledebtsecuritiesnetunrealizedloss | $6.0K | -$252.0K | -$82.0K | $1.9M | -$178.0K | -$387.0K |
Most recent annual filing with the SEC: March 2, 2026
Data sourced from SEC EDGAR public filings as of August 9, 2026.